To learn more about Covalon, please contact: Brian Pedlar, CEO, Covalon Technologies Ltd., Email: bpedlar@covalon.com, Phone: 905.568.8400 x 233, Toll free: 1.877.711.6055, Web site: www.covalon.com; Twitter: @covalonCopyright CNW Group 2015
Covalon Announces FDA Clearance for Its New SilverCoat(TM) Silicone Foley Catheter
On 6ix: 6ix.com/news/covalon-announces-fda-clearance-for-its-new-silvercoattm-silicone-foley-catheter
Watch Covalon Technologies' latest callCovalon Technologies (TSXV:COV) Q3 2026 Earnings Call · Replay · Aug 27Read the transcript of Covalon Technologies (TSXV:COV) Q3 2026 Earnings CallView original source (CNW)Covalon Technologies Ltd. on 6ix
Earlier from Covalon Technologies
- Covalon Appoints Danny Brannagan as CFO
- Covalon Announces Strong Third Quarter Results
- Covalon Announces Strong Second Quarter Results
- Covalon to Introduce MediClear(TM) Product Line at AORN
- Covalon Announces First Quarter Financial Results
Later from Covalon Technologies
- Covalon Announces Expansion into China with New Subsidiary in Shanghai
- Covalon Chairman acquires additional shares and warrants
- Covalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab Health 2016
- Covalon Announces Annual Financial Results
- Covalon Licenses Intellectual Property to Prevent Ventilator-Associated Pneumonia from the University of Michigan
Follow Covalon Technologies into a list and get an email when it puts out news.
Follow Covalon Technologies